Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: J Cell Physiol. 2010 Apr;223(1):209–214. doi: 10.1002/jcp.22028

FIGURE 3.

FIGURE 3

Kifunensin (KIF), a type 1 mannosidase inhibitor which disrupts proper processing of N-glycosylated glycoproteins, reduces the level Muc4 in cornea epithelial cells. Corneal epithelial cells from 10 day cultures were treated with indicated concentrations of KIF for 18 hours and analyzed by immunoblotting.